Cortisol as a risk biomarker to guide recovery from substance use disorders.
| Title: | Cortisol as a risk biomarker to guide recovery from substance use disorders. |
|---|---|
| Authors: | Fitzpatrick-Schmidt T; Department of Physiology and Comprehensive Alcohol-HIV/AIDS Research Center, LSU Health, New Orleans, Louisiana, USA.; Edwards S; Department of Physiology and Comprehensive Alcohol-HIV/AIDS Research Center, LSU Health, New Orleans, Louisiana, USA. |
| Source: | Alcohol, clinical & experimental research [Alcohol Clin Exp Res (Hoboken)] 2023 Mar; Vol. 47 (3), pp. 435-437. Date of Electronic Publication: 2023 Feb 21. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Comment |
| Language: | English |
| Journal Info: | Publisher: Wiley Periodicals Country of Publication: United States NLM ID: 9918609780906676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2993-7175 (Electronic) Linking ISSN: 29937175 NLM ISO Abbreviation: Alcohol Clin Exp Res (Hoboken) Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Hoboken, NJ : Wiley Periodicals, [2023]- |
| MeSH Terms: | Hydrocortisone* ; Substance-Related Disorders*; Humans ; Stress, Psychological ; Biomarkers |
| Comments: | Comment on: Alcohol Clin Exp Res. 2022 Oct;46(10):1865-1874. doi: 10.1111/acer.14913.. (PMID: 36016476) |
| References: | Sci Adv. 2021 Apr 9;7(15):. (PMID: 33837086); Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:281-5. (PMID: 23123359); Drugs. 2022 Feb;82(3):251-274. (PMID: 35133639); Neuropharmacology. 2017 Aug 1;122:136-147. (PMID: 28159647); J Neural Transm (Vienna). 2021 Jan;128(1):95-104. (PMID: 33447872); Alcohol. 2015 Dec;49(8):811-6. (PMID: 26003866); ACS Chem Neurosci. 2015 Apr 15;6(4):522-5. (PMID: 25734247); Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109150. (PMID: 34749198); J Neurosci Res. 2017 Jan 2;95(1-2):136-147. (PMID: 27870394); Alcohol Alcohol. 2021 Feb 24;56(2):181-184. (PMID: 33279964); Neurobiol Stress. 2019 Feb 01;10:100148. (PMID: 30937354); J Clin Med. 2021 Feb 16;10(4):. (PMID: 33669254); Mol Psychiatry. 2022 May;27(5):2492-2501. (PMID: 35296810); Psychoneuroendocrinology. 2014 Nov;49:299-309. (PMID: 25137484); Am J Psychiatry. 2019 Nov 1;176(11):911-922. (PMID: 31109198); J Stud Alcohol Drugs. 2021 Sep;82(5):623-628. (PMID: 34546909); Addict Behav. 2019 Sep;96:171-174. (PMID: 31102882); Psychoneuroendocrinology. 2019 Dec;110:104420. (PMID: 31499391); J Dual Diagn. 2020 Jul-Sep;16(3):322-335. (PMID: 32493131); Curr Psychiatry Rep. 2011 Oct;13(5):398-405. (PMID: 21792580); Psychopharmacology (Berl). 2017 May;234(9-10):1483-1498. (PMID: 28210782); Neuropharmacology. 2014 Jan;76 Pt B:370-82. (PMID: 23747571); J Clin Invest. 2015 Aug 3;125(8):3193-7. (PMID: 26121746) |
| Grant Information: | P60 AA009803 United States AA NIAAA NIH HHS; T35 AA021097 United States AA NIAAA NIH HHS; P50 AA009803 United States AA NIAAA NIH HHS; T32 AA007577 United States AA NIAAA NIH HHS; R01 AA025996 United States AA NIAAA NIH HHS |
| Substance Nomenclature: | WI4X0X7BPJ (Hydrocortisone); 0 (Biomarkers) |
| Entry Date(s): | Date Created: 20230222 Date Completed: 20230328 Latest Revision: 20250530 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC10050113 |
| DOI: | 10.1111/acer.15018 |
| PMID: | 36811294 |
| Database: | MEDLINE |
Journal Article; Research Support, N.I.H., Extramural; Comment